# BridgeBio Oncology Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Aug 13, 2025

- Company: [BridgeBio Oncology Therapeutics, Inc.](/companies/bbot.md) (CIK 1869105)
- Form: SCHEDULE 13D/A
- Filed: 2025-08-13
- Accepted by EDGAR: Aug 13, 2025, 12:29 ET
- Period: not reported
- Accession: 0001213900-25-075307
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1869105/000121390025075307/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1869105/000121390025075307/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1869105/000121390025075307/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-075307. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.